Article Details

GSK, CureVac Sign €150m Deal to Develop COVID-19 Vaccines

Retrieved on: 2021-02-07 04:41:15

Tags for this article:

Click the tags to see associated articles and topics

GSK, CureVac Sign €150m Deal to Develop COVID-19 Vaccines. View article details on hiswai:

Excerpt

GlaxoSmithKline Plc and CureVac N.V. yesterday disclosed that they sealed a new €150 million collaboration, to jointly develop next generation mRNA ...

Article found on: www.thisdaylive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up